Patents-Review.com
ClassID:

242672 ⎘

Y10S514/909 - CPC Classification

Classification description:

Sub-classes:
Recent Application in this class:
#1
20210299119
2021-09-30

Methods Of Providing Weight Loss Therapy In Patients With Major Depression

 #2
20190321362
2019-10-24

Methods and formulations for modulating Lyn kinase activity and treating related disorders

 #3
20190290640
2019-09-26

Methods of providing weight loss therapy in patients with major depression

 #4
20190282566
2019-09-19

Use of Flibanserin in the treatment of obesity

 #5
20190216799
2019-07-18

Compositions for affecting weight loss

 #6
20180125845
2018-05-10

Methods and formulations for modulating Lyn kinase activity and treating related disorders

 #7
20180016249
2018-01-18

Methods of Treating an Overweight or Obese Subject

 #8
20180015084
2018-01-18

Use of flibanserin in the treatment of obesity

 #9
20170007598
2017-01-12

Compositions for affecting weight loss

 #10
20160143903
2016-05-26

Methods of providing weight loss therapy in patients with major depression

 #11
20160136165
2016-05-19

Methods and formulations for modulating Lyn kinase activity and treating related disorders

 #12
20160136161
2016-05-19

Use of flibanserin in the treatment of obesity

 #13
20150361061
2015-12-17

Methods of treating an overweight or obese subject

 #14
20150150857
2015-06-04

Methods of treating an overweight or obese subject

 #15
20150133396
2015-05-14

Compositions for treating obesity and insulin resistance disorders

 #16
20140315938
2014-10-23

Compositions for controlling food intake and uses therefor

 #17
20140294915
2014-10-02

Chewing gum with tomatidine

 #18
20140288186
2014-09-25

Method for treating obesity

 #19
20140227387
2014-08-14

Chewing gum with B vitamins

 #20
20140163054
2014-06-12

Methods and formulations for treating cardiovascular disease

 #21
20140018286
2014-01-16

Amylin analogues and pharmaceutical compositions thereof

 #22
20130274293
2013-10-17

Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity

 #23
20130143892
2013-06-06

N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof

 #24
20130072555
2013-03-21

Methods for treating obesity or an obesity related condition

 #25
20130059770
2013-03-07

Amylin analogues and pharmaceutical compositions thereof

 #26
20130012427
2013-01-10

Polypeptides

 #27
20130005646
2013-01-03

Polypeptides

 #28
20120316242
2012-12-13

Methods of treating metabolic disorders

 #29
20120207768
2012-08-16

CD38 and obesity

 #30
20120196817
2012-08-02

METHOD FOR ENHANCING NUTRIENT ABSORPTION WITH ASTRAGALOSIDES

 #31
20120196816
2012-08-02

METHOD FOR ENHANCING NUTRIENT ABSORPTION WITH ASTRAGALOSIDES

 #32
20120190643
2012-07-26

Carbohydrate composition for flat glucose response

 #33
20120164264
2012-06-28

Herbal composition for weight management

 #34
20120077739
2012-03-29

Methods for treating obesity employing an SGLT2 inhibitor

 #35
20120045452
2012-02-23

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

 #36
20120045451
2012-02-23

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

 #37
20120029065
2012-02-02

Compositions for treating obesity and insulin resistance disorders

 #38
20120010232
2012-01-12

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #39
20120004162
2012-01-05

Methods of Treating an Overweight or Obese Subject

 #40
20110280974
2011-11-17

Substances having body mass redistribution properties

 #41
20110218332
2011-09-08

Nucleic acids encoding modulators of body weight

 #42
20110172260
2011-07-14

Methods of providing weight loss therapy in patients with major depression

 #43
20110086031
2011-04-14

Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance

 #44
20110060014
2011-03-10

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

 #45
20110033561
2011-02-10

Use of phytoecdysones in the preparation of a composition for acting on the metabolic syndrome

 #46
20100278804
2010-11-04

Methods for modulating Lyn kinase activity and treating related disorders

 #47
20100256209
2010-10-07

COMPOSITIONS COMPRISING ETHER COMPOUNDS AND PHARMACEUTICAL USES THEREFOR

 #48
20100190793
2010-07-29

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #49
20100183686
2010-07-22

Method to maintain the efficacy of orlistat

 #50
20100105716
2010-04-29

CaMKKβ as a target for treating obesity

 #51
20100099633
2010-04-22

Method for enhancing nutrient absorption with astragalosides

 #52
20100022474
2010-01-28

Polymer controlled induced viscosity fiber system and uses thereof

 #53
20100015086
2010-01-21

USE OF IL-22 FOR THE TREATMENT OF CONDITIONS OF METABOLIC DISORDERS

 #54
20100004160
2010-01-07

Substituted fused heterocyclic C-glycosides

 #55
20090324758
2009-12-31

Plant extract mixtures and their uses

 #56
20090318677
2009-12-24

Modulators of body weight, corresponding nucleic acids and proteins

 #57
20090298943
2009-12-03

Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders

 #58
20090274784
2009-11-05

PLANT EXTRACT MIXTURES AND THEIR USES

 #59
20090227514
2009-09-10

METHOD AND COMPOSITION USING IRVINGIA GABONENSIS FOR REDUCING BODY WEIGHT

 #60
20090226553
2009-09-10

METHOD AND COMPOSITION USING IRVINGIA GABONENSIS FOR REDUCING BODY WEIGHT

 #61
20090215718
2009-08-27

Carbohydrate composition for flat glucose response

 #62
20090214684
2009-08-27

METHOD FOR REDUCING BODY WEIGHT AND IMPROVING CONTROL OF BODY LIPIDS

 #63
20090196825
2009-08-06

CD38 and obesity

 #64
20090170095
2009-07-02

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

 #65
20090137671
2009-05-28

Methods of treating metabolic disorders

 #66
20090124592
2009-05-14

Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity

 #67
20090123579
2009-05-14

Method of promoting weight loss

 #68
20090123524
2009-05-14

PACKAGED SATIETY ENHANCING COMPOSITION

 #69
20090123380
2009-05-14

Method of assaying satiety enhancing tastants

 #70
20090111893
2009-04-30

Method of lowering blood glucose and method of treating diabetes and obesity

 #71
20090105162
2009-04-23

SUBSTITUTED FUSED HETEROCYCLIC C-GLYCOSIDES

 #72
20090075957
2009-03-19

Xanthohumol compositions and methods of using same

 #73
20090060905
2009-03-05

Use of 15-lipoxygenase inhibitors for treating obesity

 #74
20080317902
2008-12-25

Chewing gum

 #75
20080306156
2008-12-11

Method of using catalpic acid to treat hyperinsulinemia

 #76
20080268075
2008-10-30

Herbal composition weight management

 #77
20080242678
2008-10-02

Use of flibanserin in the treatment of obesity

 #78
20080234367
2008-09-25

Methods for treating obesity employing an SGLT2 inhibitor

 #79
20080227865
2008-09-18

COLIPSE-LIPASE INHIBITORS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION IN ORDER TO PREVENT OBESITY

 #80
20080214574
2008-09-04

Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders

 #81
20080200559
2008-08-21

Substances having body mass redistribution properties

 #82
20080152732
2008-06-26

Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis

 #83
20080138314
2008-06-12

Use of IL-22 for the treatment of conditions of metabolic disorders

 #84
20080108673
2008-05-08

Prevention and treatment of obesity

 #85
20080090876
2008-04-17

Use of thianecarboxamides as dgat inhibitors

 #86
20080069799
2008-03-20

Use of IL-22 for the treatment of conditions of metabolic disorders

 #87
20080069798
2008-03-20

Use of IL-22 for the treatment of conditions of metabolic disorders

 #88
20080021418
2008-01-24

LIPOLYSIS STIMULATOR

 #89
20080019940
2008-01-24

Protein conjugates with a water-soluble biocompatible, biodegradable polymer

 #90
20070275970
2007-11-29

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #91
20070270450
2007-11-22

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #92
20070212429
2007-09-13

Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis

 #93
20070202204
2007-08-30

Plant extract mixtures and their uses

 #94
20070202196
2007-08-30

Plant extract mixtures and their uses

 #95
20070190185
2007-08-16

PLANT EXTRACT MIXTURES AND THEIR USES

 #96
20070173452
2007-07-26

USE OF GLP-1 ANALOGS AND DERIVATIVES ADMINISTERED PERIPHERALLY IN REGULATION OF OBESITY

 #97
20070099829
2007-05-03

Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia

 #98
20070093516
2007-04-26

Methods for modulating Lyn kinase activity and treating related disorders

 #99
20070065523
2007-03-22

Method and composition for reducing body weight and improving control of body lipids

 #100
20070048392
2007-03-01

Plant extract mixtures and their uses

 #101
20070027117
2007-02-01

Glucocorticoid receptor ligands for the treatment of metabolic disorders

 #102
20070025921
2007-02-01

Inhibition of olfactory neurosensory function to treat eating disorders and obesity

 #103
20060263450
2006-11-23

METHOD AND COMPOSITION FOR REDUCING BODY WEIGHT AND IMPROVING CONTROL OF BODY LIPIDS

 #104
20060229260
2006-10-12

Substituted fused heterocyclic C-glycosides

 #105
20060223796
2006-10-05

Compounds for use in weight loss and appetite suppression in humans

 #106
20060199869
2006-09-07

Lipase-colipase inhibitor

 #107
20060173001
2006-08-03

Compounds for use in weight loss and appetite suppression in humans

 #108
20060166981
2006-07-27

Compounds for use in weight loss and appetite suppression in humans

 #109
20060165758
2006-07-27

Polymer controlled induced viscosity fiber system and uses thereof

 #110
20060160898
2006-07-20

Method of using catalpic acid to treat type 2 diabetes and associated disorders

 #111
20060160795
2006-07-20

Compounds for use in weight loss and appetite suppression in humans

 #112
20060148795
2006-07-06

Compounds for use in weight loss and appetite suppression in humans

 #113
20060142290
2006-06-29

Compositions for affecting weight loss

 #114
20060135567
2006-06-22

Comprehensive pharmacologic therapy for treatment of obesity

 #115
20060116341
2006-06-01

Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity

 #116
20060111435
2006-05-25

Compositions for treating obesity and insulin resistance disorders

 #117
20060106097
2006-05-18

Metabolism-modulating agents and uses therefor

 #118
20060083779
2006-04-20

Diiodothyroacetic acid and method of use

 #119
20060024354
2006-02-02

Confectionary product containing functional ingredients

 #120
20060014758
2006-01-19

Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor

 #121
20050287233
2005-12-29

Compositions for preventing or ameliorating multiple risk factor syndromes

 #122
20050284812
2005-12-29

Process for preparing water soluble diterpenes and their applications

 #123
20050282904
2005-12-22

Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight

 #124
20050282894
2005-12-22

Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight

 #125
20050261378
2005-11-24

Process for decreasing adiposity using vitamin A as a dietary supplement

 #126
20050261373
2005-11-24

Prostaglandin compounds for the treatment of obesity

 #127
20050261206
2005-11-24

Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof

 #128
20050261205
2005-11-24

Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof

 #129
20050256033
2005-11-17

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

 #130
20050250160
2005-11-10

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

 #131
20050249829
2005-11-10

Compounds for altering food intake in humans

 #132
20050233008
2005-10-20

Comprehensive pharmacologic therapy for treatment of a dysfunction

 #133
20050202101
2005-09-15

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

 #134
20050137143
2005-06-23

Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof

 #135
20050136138
2005-06-23

Synergistic composition for treating hyperilipdemia

 #136
20050119333
2005-06-02

Compositions comprising ether compounds and pharmaceutical uses therefor

 #137
20050106218
2005-05-19

Compositions and methods for treatment of body weight conditions

 #138
20050100614
2005-05-12

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

 #139
20050085535
2005-04-21

Lipase inhibiting polymers

 #140
20050080026
2005-04-14

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

 #141
20050079203
2005-04-14

Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders

 #142
20050075285
2005-04-07

GSSP4 polynucleotides and polypeptides and uses thereof

 #143
20050065190
2005-03-24

Comprehensive pharmacologic therapy for treatment of obesity including cysteine

 #144
20050065092
2005-03-24

Method of reducing adipocyte growth in a subject in need thereof by administration of natriuretic peptide receptor C inhibitors

 #145
20050064049
2005-03-24

Lipolysis stimulator

 #146
20050051483
2005-03-10

Process for preparing water soluble diterpenes and their applications

 #147
20050049203
2005-03-03

Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor

 #148
20050037980
2005-02-17

Substituted fused heterocyclic C-glycosides

 #149
20050020538
2005-01-27

Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan

 #150
20050019409
2005-01-27

Gastric retention dosage form having multiple layers

 #151
20050004082
2005-01-06

Ether compounds

 #152
14845012
2019-05-07

Method for transnasal delivery of anticonvulsant and therapeutic treatments